[134 Pages Report] The ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 101.0 million in 2017, at a CAGR of 8.5% during the forecast period. The base year considered for the study is 2017 and the forecast period is from 2018 to 2023.

The Objectives of this Study are as follows:

To define, describe, and forecast the ophthalmology PACS market by type, delivery model, end user, and region

To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast the market size of market segments in North America, Europe, Asia, Pacific countries, and the Rest of the World (RoW)

To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies3

To track and analyze competitive developments such as partnerships, agreements, and collaborations; mergers & acquisitions; product launches and enhancements; and expansions in the ophthalmology PACS market

Drivers

Rapid growth in the geriatric population

Over the years, there has been a significant increase in the geriatric population and, subsequently, the prevalence of age-related disorders, including a number of eye disorders. This is a key factor driving the demand for innovative technologies for the diagnosis and treatment of ophthalmic conditions. The tear layer loses stability and degrades faster in the elderly; consequently, the risk of getting severe eye disorders increases significantly with age, particularly after 60 years. One in three elderly people suffers from some form of eye diseases and is at risk of severe eye problems. These conditions include age-related macular degeneration, cataract, low vision, glaucoma, and diabetic eye disease.

Rising prevalence of eye diseases

The number of people with major eye diseases is increasing across the globe, and vision loss is becoming a major public health concern. The growth in aging population and the increasing prevalence of chronic disorders such as diabetes and hypertension have also served to boost the prevalence of eye diseases such as diabetic retinopathy and ocular hypertension (glaucoma). The number of blind individuals or those affected with low vision is expected to increase substantially.

According to the Royal National Institute of Blind People (RNIB), in 2013, around 2 million people in the UK were living with sight loss, which is expected to increase to 4.1 million by 2050. According to the WHO, an estimated 20 million cataract surgeries were performed in 2010 across the globe; this is expected to reach 32 million by 2020.

Research Methodology

The study estimates the ophthalmology PACS industry size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the ophthalmology PACS market. For the market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the ophthalmology PACS market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary sources include International Council of Ophthalmology (ICO), American Academy of Ophthalmology (AAO), National Eye Institute (NEI), American Optometric Association (AOA), Association for Medical Imaging Management (AHRA), Australian Diagnostic Imaging Association (ADIA), National Health Service (NHS), European Society of Ophthalmology (ESO), German Ophthalmological Society (DOG), and All India Ophthalmological Society (AIOS).

To know about the assumptions considered for the study, download the pdf brochure

The ophthalmology PACS market is marked by the presence of several big and small players. Prominent players offering ophthalmology PACS products include Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Heidelberg Engineering (Germany), Sonomed Escalon (US), Visbion (UK), EyePACS (US), and IBM Corporation (Merge Healthcare) (US).

Target Audience for this Report:

Healthcare institutions (hospitals, specialty clinics, laboratories, and medical schools)

EHR/EMR vendors

Healthcare IT companies

Research institutes

Government associations

Market research and consulting firms

Venture capitalists and investors

Expansions (2015�2018)

Month & Year Company Country Description February 2018 Carl Zeiss Meditec AG Asunci�n, ‎

Paraguay ZEISS and Christoffel-Blindenmission (CBM) along with local partner Fundaci�n Visi�n established a training center for ophthalmologists. This center utilizes all the equipment and solutions developed by ZEISS for ophthalmology diagnosis and treatment. September 2017 Carl Zeiss Meditec AG Germany The company invested USD 36.1 million (EURO 30 million) in an innovation hub at the Karlsruhe Institute of Technology (KIT), Germany, to build new technologies in the ophthalmic industry.

Mergers and Acquisitions (2015�2018)

Month & Year Strategy Acquirer Acquiree Description April 2018 Acquisition Topcon Corporation KIDE Clinical Systems Oy (Finland) This acquisition enabled the company to enhance its ophthalmology product segment by adding KIDE�s optical and ophthalmology cloud solutions to its product portfolio. August 2017 Acquisition Carl Zeiss Meditec AG Veracity Innovations, LLC (US) To focus on advancing digitalization in medical technology by expanding its market-leading digital solutions for eye care with the acquisition of an intelligent cloud-based platform offered by Veracity, which provides doctors fast and easy access to relevant clinical data at each step in the care and treatment of patients.

Product Launches and Enhancements (2015�2018)

Year Company Segment Product November 2017 Carl Zeiss Meditec AG Ophthalmology and Optometry The company launched its VERACITY Surgical, Clarus 500, and HFA3. October 2016 Topcon Corporation Eye Care IMAGEnet Connect

Partnerships, Collaborations, and Agreements (2015�2018)

Year Deal Type Company 1 Company 2 Description Jan-18 Agreement Agfa HealthCare Premier Inc. (US) Signed a group purchasing agreement through which Primer could take advantage of special pricing and terms pre-negotiated for the Agfa HealthCare Enterprise Imaging IT solutions, including PACS, universal image viewer, workflow, and VNA for various medical applications Jun-16 Partnership IBM Watson Health 16 medical providers and imaging technology companies IBM partnered with 16 medical providers and imaging technology companies to develop new ways to use medical imaging to predict various health conditions. These companies include Agfa HealthCare (Belgium), Anne Arundel Medical Center (US), Baptist Health South Florida (US), Eastern Virginia Medical School (US), Hologic (US), ifa systems AG (Germany), inoveon (US), Radiology Associates of South Florida (US), Sentara Healthcare (US), Sheridan Healthcare (US), Topcon (Japan), UC Sand Diego Health (US), University of Miami Health System (US), University of Vermont Health Network (US), and vRad (US).

Scope of the Report

This report categorizes the ophthalmology PACS market into the following segments and subsegments:

Ophthalmology PACS Market, By Type

Integrated PACS

Standalone PACS

Ophthalmology PACS Market, By Delivery Model

On-premise

Web/cloud-based

Ophthalmology PACS Market, By End User

Hospitals

Specialty Clinics & Ambulatory Surgery Centers

Other End Users (Medical Education Centers, Eye Research Institutes, and Laboratories)

Ophthalmology PACS Market, By Region

North America

US

Canada

Europe Germany France UK Rest of Europe (RoE)

Asia Japan China India Singapore Rest of Asia (RoA)

Pacific Countries

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

The ophthalmology PACS market is projected to reach USD 160.2 million by 2023 from an estimated USD 106.6 million in 2018, at a CAGR of 8.5% during the forecast period. The growth of the ophthalmology market is driven by the rapid growth in the geriatric population, rising prevalence of eye diseases, limited number of ophthalmologists, government initiatives to encourage the adoption of EHR/EMR, and the increasing adoption of teleophthalmology.

The report segments the ophthalmology market by type, delivery model, end user, and region.

Based on type, the ophthalmology PACS market is segmented into standalone and integrated PACS. The integrated PACS segment is expected to command the largest share of the ophthalmology PACS market in 2018. Integrated PACS offer advantages like ease of deployment and use, easy interoperability, data security, portability, and cost-effectiveness. These advantages are encouraging their adoption and thus driving the growth of this segment.

On the basis of delivery model, the ophthalmology PACS market is segmented into on-premise and web/cloud-based models. In 2018, the on-premise models segment is expected to account for the largest share of the ophthalmology PACS market. This can be attributed to the fact that on-premise models are more customizable than web/cloud-based models.

Based on end user, the ophthalmology PACS market is segmented into hospitals, specialty clinics & ambulatory surgery centers, and other end users. In 2018, the specialty clinics & ambulatory surgical centers segment is expected to command the largest share of the ophthalmology PACS market. The growing patient pool for the diagnosis and treatment of cataracts in specialty clinics & ASCs due to cost-effective treatments is expected to propel the growth of the ophthalmology PACS market in this end-user segment.

The market is dominated by North America, followed by Europe. The dominance of the North American market is attributed to factors such as growing aging population and increasing incidence of age-related eye diseases. Additionally, government initiatives towards digitization and increasing adoption of EHR/EMR and data storage & exchange solutions are additional factors driving the adoption of ophthalmology PACS in this region.

While the ophthalmology market represents significant growth opportunities, market growth may be hindered due to the high implementation and maintenance costs of these solutions.

The ophthalmology market is marked by the presence of several big and small players. IBM Corporation (Merge Healthcare) (US), Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Heidelberg Engineering (Germany), Sonomed Escalon (US), Visbion (UK), EyePACS (US), VersaSuite (US), Medical Standard (South Korea), ScImage (US), Agfa-Gevaert Group (Belgium), and Canon USA Inc. (US) are some of the prominent players offering ophthalmology products.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst